title: Management of chronic hepatitis C treatment failures: role of consensus interferon.
abstract: A significant proportion of patients with chronic hepatitis C virus (HCV) infection who undergo antiviral therapy have persistent or recurrent viremia and fail to achieve a sustained virologic response (SVR). Factors associated with treatment failure include HCV genotype 1 infection, high serum HCV RNA levels, and advanced fibrosis. Consensus interferon (CIFN) is a synthetic type I interferon derived from a consensus sequence of the most common amino acids found in naturally occurring alpha interferon subtypes. Several prospective clinical studies have demonstrated that CIFN may be a treatment option in patients who have failed prior interferon-based therapy, including those who have failed combination therapy with standard interferon or peginterferon plus ribavirin. Daily CIFN in combination with ribavirin may be an effective regimen in this setting; however, optimal dose and treatment duration of CIFN therapy have not been well established. Patients who achieve viral suppression during prior interferon-based therapy and those who do not have advanced fibrosis have a greater likelihood of achieving a SVR with CIFN retreatment. Individualized therapy targeting specific patient groups will be an important consideration in the successful management of prior treatment failures. Additional prospective studies are required in order to identify optimal treatment strategies for the use of CIFN in these patients.
authors.affiliation: Division of Hepatology, Baylor Regional Transplant Institute, Baylor All Saints Medical Center, Fort Worth and Baylor University Medical Center, Dallas, TX, USA.
authors.forename: Stevan A
authors.initials: SA
authors.lastname: Gonzalez
authors.forename: Emmet B
authors.initials: EB
authors.lastname: Keeffe
references.citation: N Engl J Med. 1986 Dec 18;315(25):1575-8
references.pmid: 3097544
references.citation: Hepatology. 2004 Apr;39(4):1147-71
references.pmid: 15057920
references.citation: Hepatol Res. 2003 Dec;27(4):253-259
references.pmid: 14662112
references.citation: J Hepatol. 2005 Aug;43(2):243-9
references.pmid: 16082735
references.citation: J Interferon Cytokine Res. 1996 Jul;16(7):489-99
references.pmid: 8836913
references.citation: Am J Gastroenterol. 1999 Dec;94(12):3583-8
references.pmid: 10606323
references.citation: Ann Intern Med. 2004 Mar 2;140(5):346-55
references.pmid: 14996676
references.citation: Lancet. 1998 Oct 31;352(9138):1426-32
references.pmid: 9807989
references.citation: J Hepatol. 2006 Feb;44(2):291-301
references.pmid: 16360972
references.citation: Clin Liver Dis. 2005 May;9(2):329-46, viii
references.pmid: 15831277
references.citation: Hepatology. 2003 Sep;38(3):645-52
references.pmid: 12939591
references.citation: Liver Int. 2006 Apr;26(3):319-25
references.pmid: 16584394
references.citation: Gut. 2006 Nov;55(11):1631-8
references.pmid: 16709661
references.citation: Dig Liver Dis. 2007 Jan;39(1):47-51
references.pmid: 17079197
references.citation: J Virol. 2004 Aug;78(15):8219-28
references.pmid: 15254193
references.citation: J Hepatol. 2007 Apr;46(4):596-604
references.pmid: 17218037
references.citation: Gastroenterology. 2008 Sep;135(3):821-9
references.pmid: 18593587
references.citation: Gastroenterology. 2004 Apr;126(4):1015-23; discussion 947
references.pmid: 15057741
references.citation: N Engl J Med. 2004 May 27;350(22):2265-71
references.pmid: 15163776
references.citation: N Engl J Med. 1998 Nov 19;339(21):1485-92
references.pmid: 9819446
references.citation: Dig Dis Sci. 2007 Jun;52(6):1540-7
references.pmid: 17406822
references.citation: Lancet. 2001 Sep 22;358(9286):958-65
references.pmid: 11583749
references.citation: J Viral Hepat. 2002 Sep;9(5):334-9
references.pmid: 12225327
references.citation: Hepatology. 1997 Sep;26(3):747-54
references.pmid: 9303508
references.citation: Dig Dis Sci. 2006 Nov;51(11):1956-61
references.pmid: 17004124
references.citation: Gastroenterology. 2006 Apr;130(4):1086-97
references.pmid: 16618403
references.citation: Gastroenterology. 2006 Apr;130(4):1098-106
references.pmid: 16618404
references.citation: J Hepatol. 2003 Nov;39(5):843-9
references.pmid: 14568269
references.citation: World J Gastroenterol. 2006 Nov 14;12(42):6861-4
references.pmid: 17106937
references.citation: Gastroenterology. 2002 May;122(5):1303-13
references.pmid: 11984517
references.citation: Nature. 2005 Aug 18;436(7053):939-45
references.pmid: 16107833
references.citation: Hepatology. 1998 Apr;27(4):1136-43
references.pmid: 9537455
references.citation: N Engl J Med. 2002 Sep 26;347(13):975-82
references.pmid: 12324553
references.citation: Am J Gastroenterol. 2008 Nov;103(11):2727-36; quiz 2737
references.pmid: 18684170
references.citation: J Gastroenterol. 2002;37(9):732-6
references.pmid: 12375147
references.citation: Eur J Gastroenterol Hepatol. 2002 May;14(5):477-83
references.pmid: 11984144
references.citation: Dig Dis Sci. 2005 Apr;50(4):727-32
references.pmid: 15844709
references.citation: Dig Dis Sci. 2008 Jul;53(7):1961-6
references.pmid: 18219576
references.citation: Am J Gastroenterol. 2005 Nov;100(11):2453-62
references.pmid: 16279900
references.citation: Can J Gastroenterol. 2003 Aug;17(8):479-82
references.pmid: 12945008
references.citation: Hepatology. 2002 Nov;36(5 Suppl 1):S35-46
references.pmid: 12407575
references.citation: Hepatology. 1999 Aug;30(2):562-6
references.pmid: 10421669